Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer .Phase Ⅰ trial of targeted therapy with PSA-TRICOM vaccine ( V ) and ipilimumab ( ipi ) in patients ( pts ) with metastatic castration-resistant p ......